bpc-157 periodontal regeneration study 1209_S7_article_14 Frontiers | Stable Gastric Pentadecapeptide

From a regulatory standpoint, Epithalon is not FDA-approved and lacks comprehensive human safety data within Western regulatory frameworks

At 10mg/mL, 25 units delivers 2.5mg

A randomized phase II clinical trial showed that this antibody in combination with epirubicin, cisplatin, and capecitabine (ECX) could prolong PFS in advanced gastric cancer patients relative to the control group, especially in patients with high c-Met expression ( Onartuzumab is a recombinant humanized anti-c-Met monoclonal antibody, which is produced in Escherichia coli (Shah et al., 2016)

Specific peptides like BPC-157, Thymosin Beta-4, GHK-Cu, and Kisspeptin offer targeted benefits for maternal health

PMID: 6689058